Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | NOS2 | P35228 | 1/20 | 0.52 |
| ▸ | BACE1 | P56817 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 8/20 | 0.46 |
| ▸ | RAB9A | P51151 | 8/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | PKM | P14618 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.46 |
| ▸ | RELA | Q04206 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29862377 | 1.00 | NCF1 (0.52) | NCF1CYP1A2NOS2BACE1CA12 | |
| SCHEMBL19219874 | 1.00 | NCF1 (0.52) | NCF1CYP1A2NOS2BACE1CA12 | |
| Benzene SCHEMBL27864621 | 0.97 | NCF1 (0.50) | NCF1CYP1A2NOS2BACE1CA12 | |
| Hydrochloric Acid SCHEMBL6529182 | 0.97 | NCF1 (0.50) | NCF1CYP1A2NOS2BACE1CA12 | |
| Quinoline SCHEMBL28157094 | 0.87 | ALDH1A1 (0.68) | NCF1CYP1A2NOS2BACE1CA12 | |
| SCHEMBL17962365 | 0.87 | NCF1 (0.47) | NCF1CYP1A2NOS2BACE1CA12 | |
| Acetone SCHEMBL22352606 | 0.87 | KDM4E (0.50) | NCF1CYP1A2NOS2BACE1MAPT | |
| Benzenesulfonamide SCHEMBL20358013 | 0.80 | CA1 (0.53) | NCF1NOS2BACE1CA12CA9 | |
| Hydrochlorthiazide SCHEMBL28012369 | 0.80 | RAB9A (0.39) | NCF1CYP1A2NOS2BACE1CA12 | |
| SCHEMBL18092688 | 0.78 | CA12 (0.65) | CA12CA9ALDH1A1HPGDNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1530 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144251-A1 | ANTIMICROBIAL NANOCLAYS COMPRISING CATIONIC ANTIMICROBIALS, METHOD OF PREPARATION AND USES THEREOF | POLYAMYNA NANOTECH INC. (CA) | 2026-05-28 | — | — | US | claimed |
| CN-117865932-B | Preparation method of benzothiophene sulfone compound with medicinal and fluorescent activity | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2026-05-26 | — | — | CN | claimed |
| US-12564575-B2 | Early management, mitigation and prevention of sepsis and sepsis-like syndromes, including neo-natal ARDS due to infection, injury or iatrogenesis | OPHIREX, INC (US) | 2026-03-03 | — | — | US | claimed |
| CN-119842078-A | Polysulfone resin, preparation method thereof and polymer product | 深圳市沃特新材料股份有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-119221207-A | Fluorescent flexible fiber membrane dosimeter and preparation method and application thereof | 南京航空航天大学 | 2024-12-31 | — | — | CN | claimed |
| US-20240390375-A1 | METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS | Viracta Subsidiary, Inc. (US) | 2024-11-28 | — | — | US | claimed |
| CN-118922081-A | Insect, acarina and nematode pest control | 先正达农作物保护股份公司 | 2024-11-08 | — | — | CN | claimed |
| CN-117865932-A | Preparation method of benzothiophene sulfone compound with medicinal and fluorescent activity | 北京化工大学 | 2024-04-12 | — | — | CN | claimed |
| CN-117320552-A | Insect, acarina and nematode pest control | 先正达农作物保护股份公司 | 2023-12-29 | — | — | CN | claimed |
| EP-4255994-A1 | CLEAR COATING ANTIMICROBIAL COMPOSITIONS, METHODS OF PREPARATION, AND USES THEREOF FOR CONFERRING ANTIMICROBIAL ACTIVITY TO A SURFACE | Polyamyna Nanotech Inc. (CA) | 2023-10-11 | — | — | EP | claimed |
| EP-1250116-A1 | PHARMACEUTICAL AND COSMETIC CARRIER OR COMPOSITION FOR TOPICAL APPLICATION | Thixo Ltd. (IL) | 2002-10-23 | — | — | EP | claimed |
| WO-2002074290-A2 | DERMATOLOGICAL PREPARATIONS CONTAINING A NSAID | AGIS INDUSTRIES (1983) LTD. (IL) | 2002-09-26 | — | — | WO | claimed |
| EP-1194124-A1 | TASTE MASKED COMPOSITIONS | Ranbaxy Laboratories Limited (IN) | 2002-04-10 | — | — | EP | claimed |
| WO-2001051014-A1 | PHARMACEUTICAL AND COSMETIC CARRIER OR COMPOSITION FOR TOPICAL APPLICATION | THIXO LTD (IL) | 2001-07-19 | — | — | WO | claimed |
| WO-2000076479-A1 | TASTE MASKED COMPOSITIONS | RANBAXY LABORATORIES LIMITED (IN) | 2000-12-21 | — | — | WO | claimed |
| EP-0641341-B1 | METHOD FOR PREPARING BENZO [b]NAPHTHYRIDINES | RHONE POULENC RORER SA (FR) | 2000-03-01 | — | — | EP | claimed |
| US-5798115-A | BIOCOMPATIBLE POLYMER COMPRISING AN ACTIVE DRUG ON POLYMER BACKBONE; BIODEGRADABLE, RELEASING THE DRUG | INTERFACE BIOLOGICS (CA) | 1998-08-25 | — | — | US | claimed |
| US-5776948-A | BACTERICIDE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 1998-07-07 | — | — | US | claimed |
| US-5484921-A | Process for preparing benzo[b]naphthyridines | LABORATOIRE ROGER BELLON (FR) | 1996-01-16 | — | — | US | claimed |
| EP-0664288-A1 | FLUOROQUINOLINE DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 1995-07-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144251-A1 | ANTIMICROBIAL NANOCLAYS COMPRISING CATIONIC ANTIMICROBIALS, METHOD OF PREPARATION AND USES THEREOF | KLF10, SLC11A2, SLC7A11 | NCF1 968/4885CYP1A2 4682/4885NOS2 1129/4885 |
| US-12564575-B2 | Early management, mitigation and prevention of sepsis and sepsis-like syndromes, including neo-natal ARDS due to infection, injury or iatrogenesis | PLA2G12A, PLA2G3, PLA2G1B | NCF1 2792/4885CYP1A2 1315/4885NOS2 2558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.